Immunointervention for patients with HIV and tuberculosis
Data(s) |
01/06/2009
|
---|---|
Resumo |
Therapeutic options aimed at confronting the HIV pandemic face many obstacles. Current opinion on HIV-induced pathogenic immune activation and strategies aimed at eliminating HIV, including a potential role for non-neutralising antibodies as part of a therapeutic vaccine option, was elegantly reviewed by Martin Cadogan and Angus Dalgleish. 1 It is important to note that, for eliciting such antibody responses in patients, functionally fit antigen presenting cells and effector T and B cells are cruc. |
Formato |
application/pdf |
Identificador |
http://eprints.iisc.ernet.in/20991/1/mkq.pdf Vani, Janakiraman and Bansai, Kushagra and Kazatchkine, Michel D and Kaveri, Srini V and Bayry, Jagadeesh (2009) Immunointervention for patients with HIV and tuberculosis. In: Lancet Infectious Diseases, The, 9 (6). pp. 332-333. |
Publicador |
The Lancet |
Relação |
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W8X-4WBT6H2-2&_user=512776&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000025298&_version=1&_urlVersion=0&_userid=512776&md5=512c1b46c74a910929d775a9ddbb3255 http://eprints.iisc.ernet.in/20991/ |
Palavras-Chave | #Microbiology & Cell Biology |
Tipo |
Journal Article PeerReviewed |